Whitehawk Therapeutics (WHWK) Capital Expenditures (QoQ) (2016 - 2025)
Whitehawk Therapeutics (WHWK) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Whitehawk Therapeutics |
288.03 Mn |
164.98 Mn |
- |
| Date | Value |
| Jun 30, 2025 |
-200.00% |
| Mar 31, 2025 |
274.92% |
| Dec 31, 2024 |
-135.92% |
| Sep 30, 2024 |
692.57% |
| Jun 30, 2024 |
-120.03% |
| Mar 31, 2024 |
-80.81% |
| Dec 31, 2023 |
298.86% |
| Sep 30, 2023 |
-215.86% |
| Jun 30, 2023 |
331.78% |
| Mar 31, 2023 |
396.15% |
| Dec 31, 2022 |
-75.24% |
| Sep 30, 2022 |
1,025.00% |
| Jun 30, 2022 |
21.74% |
| Dec 31, 2019 |
-100.02% |
| Sep 30, 2019 |
-96.41% |
| Jun 30, 2019 |
5.39% |
| Mar 31, 2019 |
1,227.74% |
| Dec 31, 2018 |
-59.14% |
| Mar 31, 2018 |
261.77% |
| Jun 30, 2017 |
96.51% |